SOLUBLE TRIGGERING RECEPTOR S-TREM-1 USED FOR ACTIVATING THE MYELOID CELLS AND CONTROLLING THE EFFICIENCY OF THE PEPTIC ULCER TREATMENT

摘要

The invention relates to the use of a polypeptide (sTREM-1)-a soluble receptor triggering the myeloid cells- determined in the blood serum of patients suffering from peptic ulcer. The patients are subjected to blood examinations before and after the treatment administrated for healing the peptic ulcer. The method in question aims at controlling the efficiency of the ulcer therapy and evaluating the potential necessity of a further therapeutic intervention.